GlassScriptPhysician profile
Kenneth R Smith
NPI 1386619021
$603.03
in general payments reported to CMS, 2019-2025
7 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $170 · 2021: $73.58 · 2023: $121 · 2024: $238.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $359.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $359.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Surgical Vision, INC. | $177.14 | 2023-2024 | Tecnis Iol |
| Alcon Vision LLC | $156.99 | 2020-2024 | Argos |
| Astellas Pharma US INC | $120.84 | 2024 | Izervay |
| Kala Pharmaceuticals, INC. | $54.16 | 2020 | |
| Novartis Pharmaceuticals Corporation | $40.42 | 2021 | |
| Biotissue Holdings INC. | $33.16 | 2021 | |
| Bausch & Lomb Americas INC. | $20.32 | 2024 | Ic-8 Apthera Iol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.